Published Paper Details:

The coronavirus disease (COVID -19) has become one of the most threatening diseases of the world. COVID-19 is a respiratory tract infection caused by novel SARS-CoV-2 strain. The second wave of this pandemic emerged as challenges and concerns to India, because of Coronavirus disease associated fungal infections mucormycosis and candidiasis. Mucormycosis, otherwise called as black fungus is a emerging deadly infection caused by a group of fungi known as mucormycetes which is commonly present in the environment particularly in soils and in association with decaying organic matter. Candidiasis or white fungus disease is caused by Candida albicans. These fungi infects mainly immunocompromised people, since they are affected the diseases like diabetes mellitus and human immunodeficiency virus infection (HIV). Opportunistic fungal pathogens infects COVID patients, the reason is coronavirus disease managed by steroids. The current scenario in India mucormycosis cases are reported in 18 states and candidiasis reported in 2 states. Currently the treatment for black fungus and white fungus is by using drugs amphotericin and triazoles etc. In this study discuss about the scenario of black and white fungal infections in India and natural low-cost herbal plants as medicines for the management of associated fungal co-infections. Medicinal plants are a good source for antifungal properties, therapeutic value, and cost effective and broad-spectrum antifungal agents.